These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25640657)

  • 1. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
    Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
    Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
    Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.
    Kaur G; STS C; Nimker C; Bansal A
    Cell Mol Immunol; 2015 Jan; 12(1):96-106. PubMed ID: 24858422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
    Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
    Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection.
    Bansal A; Paliwal PK; Sagi SS; Sairam M
    Mol Cell Biochem; 2010 Apr; 337(1-2):213-21. PubMed ID: 19851830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.
    Heine SJ; Diaz-McNair J; Martinez-Becerra FJ; Choudhari SP; Clements JD; Picking WL; Pasetti MF
    Vaccine; 2013 Jun; 31(28):2919-29. PubMed ID: 23644075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of
    Turbyfill KR; Clarkson KA; Vortherms AR; Oaks EV; Kaminski RW
    mSphere; 2018; 3(2):. PubMed ID: 29600284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous expression of Intimin and IpaB fusion protein in Lactococcus lactis and its mucosal delivery elicit protection against pathogenicity of Escherichia coli O157 and Shigella flexneri in a murine model.
    Sagi S; Konduru B; Parida M
    Int Immunopharmacol; 2020 Aug; 85():106617. PubMed ID: 32464569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly protective Shigella vaccine based on type III secretion apparatus proteins.
    Martinez-Becerra FJ; Kissmann JM; Diaz-McNair J; Choudhari SP; Quick AM; Mellado-Sanchez G; Clements JD; Pasetti MF; Picking WL
    Infect Immun; 2012 Mar; 80(3):1222-31. PubMed ID: 22202122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant heat shock protein 60 (Hsp60/GroEL) of Salmonella enterica serovar Typhi elicits cross-protection against multiple bacterial pathogens in mice.
    Chitradevi ST; Kaur G; Singh K; Sugadev R; Bansal A
    Vaccine; 2013 Apr; 31(16):2035-41. PubMed ID: 23474314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella.
    Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME
    Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.
    Heine SJ; Franco-Mahecha OL; Chen X; Choudhari S; Blackwelder WC; van Roosmalen ML; Leenhouts K; Picking WL; Pasetti MF
    Immunol Cell Biol; 2015 Aug; 93(7):641-52. PubMed ID: 25776843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.
    Heine SJ; Diaz-McNair J; Andar AU; Drachenberg CB; van de Verg L; Walker R; Picking WL; Pasetti MF
    J Immunol; 2014 Feb; 192(4):1630-40. PubMed ID: 24453241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Paliwal PK; Bansal A; Sagi SS; Sairam M
    Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection.
    Kaur G; STS C; Nimker C; Singh M; Saraswat D; Saxena S; Bansal A
    Immunol Cell Biol; 2013; 91(10):642-51. PubMed ID: 24145856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane protein A (OmpA) of Shigella flexneri 2a, induces protective immune response in a mouse model.
    Pore D; Mahata N; Pal A; Chakrabarti MK
    PLoS One; 2011; 6(7):e22663. PubMed ID: 21818362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.
    Kim JO; Rho S; Kim SH; Kim H; Song HJ; Kim EJ; Kim RY; Kim EH; Sinha A; Dey A; Yang JS; Song MK; Nandy RK; Czerkinsky C; Kim DW
    Clin Vaccine Immunol; 2015 Apr; 22(4):381-8. PubMed ID: 25651919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection.
    van de Verg LL; Mallett CP; Collins HH; Larsen T; Hammack C; Hale TL
    Infect Immun; 1995 May; 63(5):1947-54. PubMed ID: 7729907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SipD and IpaD induce a cross-protection against Shigella and Salmonella infections.
    Jneid B; Rouaix A; Féraudet-Tarisse C; Simon S
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008326. PubMed ID: 32463817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive immunity with multi-serotype heat-killed Shigellae in neonatal mice.
    Barman S; Koley H; Nag D; Shinoda S; Nair GB; Takeda Y
    Microbiol Immunol; 2014 Aug; 58(8):463-6. PubMed ID: 24909404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.